World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 23 March 2015
Main ID:  NCT02387567
Date of registration: 22/05/2014
Prospective Registration: No
Primary sponsor: Marta Imamura
Public title: Paraspinal Block in Nonspecific Low Back Pain
Scientific title: Study on the Effects of Paraspinal Lidocaine Injection on Nonspecific Low Back Pain
Date of first enrolment: January 2007
Target sample size: 378
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02387567
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  Phase 3
Countries of recruitment
Brazil
Contacts
Name:     Marta Imamura, MD
Address: 
Telephone:
Email:
Affiliation:  Instituto de Medicina Física e Reabilitação HCFMUSP
Key inclusion & exclusion criteria

Inclusion criteria:

- Age between 20 to 60 years;

- Clinical symptoms of vertebral pain that is unresponsive to symptomatic treatment
with anti-inflammatory drugs for 3 months;

- Moderate to severe pain: visual analog scale (VAS) > 4;

- Diagnosis of chronic nonspecific low back pain;

- MiniMental test (MEEM) between 24 and 30;

- Availability to comply with the visits;

- Agree with signing the Informed Consent Form

Exclusion criteria:

- Severe psychiatric disease that requires psychiatric care;

- Neurological disorders (lumbosciatic pain);

- Concurrent fibromyalgia, per the 1990 diagnostic criteria of the American Academy of
Rheumatology

- Concurrent rheumatic disease

- History of allergy to lidocaine (used for paraspinal blocks)

- Labor problems

- History of surgery on the lumbar spine

- No availability to visit the clinic for treatment and evaluations.



Age minimum: 20 Years
Age maximum: 60 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Chronic Low Back Pain
Intervention(s)
Drug: Sham Lidocaine
Other: Standard treatment
Drug: Lidocaine
Primary Outcome(s)
Change from baseline in pain on the visual analog scale (VAS) score for pain at week 1 [Time Frame: Baseline, week 1]
Secondary Outcome(s)
Change from baseline in pain on the Brazilian Roland-Morris tool at week 1 [Time Frame: Baseline, week 1]
Change from baseline in pain on the visual analog scale (VAS) score for pain [Time Frame: Baseline, week 12]
Change from baseline in pain on the Brazilian Roland-Morris tool at week 12 [Time Frame: baseline, week 12]
Secondary ID(s)
U1111-1155-7609
PS-block-Pain
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Spaulding Rehabilitation Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history